Page last updated: 2024-10-27

gliclazide and Angor Pectoris

gliclazide has been researched along with Angor Pectoris in 2 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Research Excerpts

ExcerptRelevanceReference
"Gliclazide is an SU agent believed to be more protective."2.73'Warm-up' phenomenon in diabetic patients with stable angina treated with diet or sulfonylureas. ( Bilinska, M; Korzeniowska-Kubacka, I; Piotrowicz, R; Potocka, J, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zheng, M1
Li, LZ1
Jiang, ZA1
Li, LH1
Feng, YG1
Fu, XH1
Bilinska, M1
Potocka, J1
Korzeniowska-Kubacka, I1
Piotrowicz, R1

Trials

1 trial available for gliclazide and Angor Pectoris

ArticleYear
'Warm-up' phenomenon in diabetic patients with stable angina treated with diet or sulfonylureas.
    Coronary artery disease, 2007, Volume: 18, Issue:6

    Topics: Angina Pectoris; Blood Pressure; Diabetes Mellitus, Type 2; Exercise; Gliclazide; Glyburide; Heart R

2007

Other Studies

1 other study available for gliclazide and Angor Pectoris

ArticleYear
[Effects of different sulfonylureas on the warm-up phenomenon in diabetes patients with coronary artery disease].
    Zhonghua yi xue za zhi, 2017, Jan-17, Volume: 97, Issue:3

    Topics: Angina Pectoris; Coronary Angiography; Coronary Artery Disease; Diabetes Complications; Diabetes Mel

2017